How to decide who to treat.

J. Kanis,E. McCloskey,E. McCloskey,H. Johansson,O. Ström,F. Borgström,A. Odén

DOI: https://doi.org/10.1016/j.berh.2009.09.002

2009-12-01

Abstract:

What problem does this paper attempt to address?

Intra-aortic balloon pumping in cardiogenic shock.

C. Brantigan,Hopeman Ar

Abstract:
The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host.

Ping Yi,LanJuan Li

DOI: https://doi.org/10.1016/j.vetmic.2011.10.024

IF: 3.246

2012-01-01

Veterinary Microbiology

Abstract:Scientific findings in recent decades have demonstrated that the commensal intestinal microbiota has profound effects on the physiology and diseases of the host. It is estimated that the human microbiota is composed of 1014 bacterial cells, a number 10 times greater than the total number of human cells. The variety and the complex interactions of the intestinal microbiota are associated with physiological details that remain largely unknown. Germfree hosts, especially murine (rat or mouse) animals that have been maintained free from demonstrable microbial associates such as bacteria, viruses, fungi, and parasites throughout life, have become a powerful tool for exploring the interplay between the host and microorganisms inhabiting the human intestine. This review and survey of recent findings will argue that the germfree mouse model can produce its greatest potential benefits in the study of the metabolism and immunity of the host.
The role of the gut microbiota on animal model reproducibility

Patricia V. Turner

DOI: https://doi.org/10.1002/ame2.12022

2018-06-01

Animal Models and Experimental Medicine

Abstract:The gut microbiota is composed of approximately 10<sup>10</sup>-10<sup>14</sup> cells, including fungi, bacteria, archaea, protozoa, viruses, and bacteriophages; their genes and their various metabolites were found throughout the gastrointestinal tract. It has co-evolved with each species to assist with day to day bodily functions, such as digestion, metabolism of xenobiotics, development of mucosal immunity and immunomodulation, and protection against invading pathogens. Because of the significant beneficial impact that gut microbiota may have, there is interest in learning more about it and translating these findings into clinical therapies. Results from recent studies characterizing the gut microbiota of various species have demonstrated the range of influences that may affect gut microbiota diversity, including animal strain, obesity, types of enrichment used, bedding and housing methods, treatment with antimicrobials, vendor source, specific animal housing, diet, and intercurrent disease. Relatively little is known about the functional consequences of alterations of the gut microbiota and exactly how changes in richness and diversity of the microbiota translate into changes in health and susceptibility to disease. Furthermore, questions have been raised as to whether germ-free or even ultraclean, barrier-raised mice are relevant models of human disease, given their significantly reduced gut microbiota diversity and complexity compared with conventionally housed mice. In addition, evidence suggests that the specific anatomical location selected for assessing the gut microbiota has a highly significant effect on study outcomes, in that bacterial phyla change significantly along the gastrointestinal tract. This paper will explore animal model reproducibility in light of this information about the gut microbiota.
Controlled Complexity: Optimized Systems to Study the Role of the Gut Microbiome in Host Physiology

Robert W. P. Glowacki,Morgan J. Engelhart,Philip P. Ahern

DOI: https://doi.org/10.3389/fmicb.2021.735562

IF: 5.2

2021-09-27

Frontiers in Microbiology

Abstract:The profound impact of the gut microbiome on host health has led to a revolution in biomedical research, motivating researchers from disparate fields to define the specific molecular mechanisms that mediate host-beneficial effects. The advent of genomic technologies allied to the use of model microbiomes in gnotobiotic mouse models has transformed our understanding of intestinal microbial ecology and the impact of the microbiome on the host. However, despite incredible advances, our understanding of the host-microbiome dialogue that shapes host physiology is still in its infancy. Progress has been limited by challenges associated with developing model systems that are both tractable enough to provide key mechanistic insights while also reflecting the enormous complexity of the gut ecosystem. Simplified model microbiomes have facilitated detailed interrogation of transcriptional and metabolic functions of the microbiome but do not recapitulate the interactions seen in complex communities. Conversely, intact complex communities from mice or humans provide a more physiologically relevant community type, but can limit our ability to uncover high-resolution insights into microbiome function. Moreover, complex microbiomes from lab-derived mice or humans often do not readily imprint human-like phenotypes. Therefore, improved model microbiomes that are highly defined and tractable, but that more accurately recapitulate human microbiome-induced phenotypic variation are required to improve understanding of fundamental processes governing host-microbiome mutualism. This improved understanding will enhance the translational relevance of studies that address how the microbiome promotes host health and influences disease states. Microbial exposures in wild mice, both symbiotic and infectious in nature, have recently been established to more readily recapitulate human-like phenotypes. The development of synthetic model communities from such “wild mice” therefore represents an attractive strategy to overcome the limitations of current approaches. Advances in microbial culturing approaches that allow for the generation of large and diverse libraries of isolates, coupled to ever more affordable large-scale genomic sequencing, mean that we are now ideally positioned to develop such systems. Furthermore, the development of sophisticated in vitro systems is allowing for detailed insights into host-microbiome interactions to be obtained. Here we discuss the need to leverage such approaches and highlight key challenges that remain to be addressed.

microbiology
Identification of gut microbial species linked with disease variability in a widely used mouse model of colitis

Samuel C. Forster,Simon Clare,Benjamin S. Beresford-Jones,Katherine Harcourt,George Notley,Mark D. Stares,Nitin Kumar,Amelia T. Soderholm,Anne Adoum,Hannah Wong,Bélen Morón,Cordelia Brandt,Gordon Dougan,David J. Adams,Kevin J. Maloy,Virginia A. Pedicord,Trevor D. Lawley

DOI: https://doi.org/10.1038/s41564-022-01094-z

IF: 28.3

2022-04-01

Nature Microbiology

Abstract:Abstract Experimental mouse models are central to basic biomedical research; however, variability exists across genetically identical mice and mouse facilities making comparisons difficult. Whether specific indigenous gut bacteria drive immunophenotypic variability in mouse models of human disease remains poorly understood. We performed a large-scale experiment using 579 genetically identical laboratory mice from a single animal facility, designed to identify the causes of disease variability in the widely used dextran sulphate sodium mouse model of inflammatory bowel disease. Commonly used treatment endpoint measures—weight loss and intestinal pathology—showed limited correlation and varied across mouse lineages. Analysis of the gut microbiome, coupled with machine learning and targeted anaerobic culturing, identified and isolated two previously undescribed species, Duncaniella muricolitica and Alistipes okayasuensis , and demonstrated that they exert dominant effects in the dextran sulphate sodium model leading to variable treatment endpoint measures. We show that the identified gut microbial species are common, but not ubiquitous, in mouse facilities around the world, and suggest that researchers monitor for these species to provide experimental design opportunities for improved mouse models of human intestinal diseases.

microbiology
Microbiome Composition in Both Wild-Type and Disease Model Mice Is Heavily Influenced by Mouse Facility

Kristopher D Parker,Shannon E Albeke,Jason P Gigley,Allan M Goldstein,Naomi L Ward

DOI: https://doi.org/10.3389/fmicb.2018.01598

2018-07-20

Abstract:Murine models have become essential tools for understanding the complex interactions between gut microbes, their hosts, and disease. While many intra-facility factors are known to influence the structure of mouse microbiomes, the contribution of inter-facility variation to mouse microbiome composition, especially in the context of disease, remains under-investigated. We replicated microbiome experiments using identical mouse lines housed in two separate animal facilities and report drastic differences in composition of microbiomes based upon animal facility of origin. We observed facility-specific microbiome signatures in the context of a disease model [the Ednrb (endothelin receptor type B) Hirschsprung disease mouse] and in normal C57BL/6J mice. Importantly, these facility differences were independent of cage, sex, or sequencing-related influence. In addition, we investigated the reproducibility of microbiome dysbiosis previously associated with Ednrb-/- (knock-out; KO) mice. While we observed genotype-based differences in composition between wild-type (WT) and KO mice, these differences were inconsistent with the previously reported conclusions. Furthermore, the genotype-based differences were not identical across animal facilities. Despite this, through differential abundance testing, we identified several conserved candidate taxa and candidate operational taxonomic units that may play a role in disease promotion or protection. Overall, our findings raise the possibility that previously reported microbiome-disease associations from murine studies conducted in a single facility may be heavily influenced by facility-specific effects. More generally, these results provide a strong rationale for replication of mouse microbiome studies at multiple facilities, and for the meticulous collection of metadata that will allow the confounding effects of facility to be more specifically identified.
Temporospatial shifts within commercial laboratory mouse gut microbiota impact experimental reproducibility

Rabindra K. Mandal,Joshua E. Denny,Morgan L. Waide,Qingsheng Li,Neal Bhutiani,Charles D. Anderson,Becca V. Baby,Venkatakrishna R. Jala,Nejat K. Egilmez,Nathan W. Schmidt

DOI: https://doi.org/10.1186/s12915-020-00810-7

IF: 7.364

2020-07-03

BMC Biology

Abstract:BackgroundExperimental reproducibility in mouse models is impacted by both genetics and environment. The generation of reproducible data is critical for the biomedical enterprise and has become a major concern for the scientific community and funding agencies alike. Among the factors that impact reproducibility in experimental mouse models is the variable composition of the microbiota in mice supplied by different commercial vendors. Less attention has been paid to how the microbiota of mice supplied by a particular vendor might change over time.ResultsIn the course of conducting a series of experiments in a mouse model of malaria, we observed a profound and lasting change in the severity of malaria in mice infected with Plasmodium yoelii; while for several years mice obtained from a specific production suite of a specific commercial vendor were able to clear the parasites effectively in a relatively short time, mice subsequently shipped from the same unit suffered much more severe disease. Gut microbiota analysis of frozen cecal samples identified a distinct and lasting shift in bacteria populations that coincided with the altered response of the later shipments of mice to infection with malaria parasites. Germ-free mice colonized with cecal microbiota from mice within the same production suite before and after this change followed by Plasmodium infection provided a direct demonstration that the change in gut microbiota profoundly impacted the severity of malaria. Moreover, spatial changes in gut microbiota composition were also shown to alter the acute bacterial burden following Salmonella infection, and tumor burden in a lung tumorigenesis model.ConclusionThese changes in gut bacteria may have impacted the experimental reproducibility of diverse research groups and highlight the need for both laboratory animal providers and researchers to collaborate in determining the methods and criteria needed to stabilize the gut microbiota of animal breeding colonies and research cohorts, and to develop a microbiota solution to increase experimental rigor and reproducibility.

biology
[Subacute toxic hepatitis and perhexiline maleates].

N. Herne,A. Raillat,J. Marion,F. Le Gall,A. Chagnon

1976-10-09

Abstract:
How informative is the mouse for human gut microbiota research?

Thi Loan Anh Nguyen,Sara Vieira-Silva,Adrian Liston,Jeroen Raes

DOI: https://doi.org/10.1242/dmm.017400

2015-01-01

Abstract:The microbiota of the human gut is gaining broad attention owing to its association with a wide range of diseases, ranging from metabolic disorders (e.g. obesity and type 2 diabetes) to autoimmune diseases (such as inflammatory bowel disease and type 1 diabetes), cancer and even neurodevelopmental disorders (e.g. autism). Having been increasingly used in biomedical research, mice have become the model of choice for most studies in this emerging field. Mouse models allow perturbations in gut microbiota to be studied in a controlled experimental setup, and thus help in assessing causality of the complex host-microbiota interactions and in developing mechanistic hypotheses. However, pitfalls should be considered when translating gut microbiome research results from mouse models to humans. In this Special Article, we discuss the intrinsic similarities and differences that exist between the two systems, and compare the human and murine core gut microbiota based on a meta-analysis of currently available datasets. Finally, we discuss the external factors that influence the capability of mouse models to recapitulate the gut microbiota shifts associated with human diseases, and investigate which alternative model systems exist for gut microbiota research.

pathology,cell biology
Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design

Debby Laukens,Brigitta M Brinkman,Jeroen Raes,Martine De Vos,Peter Vandenabeele,Brigitta M. Brinkman

DOI: https://doi.org/10.1093/femsre/fuv036

2015-08-30

FEMS Microbiology Reviews

Abstract:Targeted manipulation of the gut flora is increasingly being recognized as a means to improve human health. Yet, the temporal dynamics and intra- and interindividual heterogeneity of the microbiome represent experimental limitations, especially in human cross-sectional studies. Therefore, rodent models represent an invaluable tool to study the host-microbiota interface. Progress in technical and computational tools to investigate the composition and function of the microbiome has opened a new era of research and we gradually begin to understand the parameters that influence variation of host-associated microbial communities. To isolate true effects from confounding factors, it is essential to include such parameters in model intervention studies. Also, explicit journal instructions to include essential information on animal experiments are mandatory. The purpose of this review is to summarize the factors that influence microbiota composition in mice and to provide guidelines to improve the reproducibility of animal experiments.

microbiology
Integrating natural commensals and pathogens into preclinical mouse models

Barbara Rehermann,Andrea L. Graham,David Masopust,Sara E. Hamilton

DOI: https://doi.org/10.1038/s41577-024-01108-3

IF: 108.555

2024-11-24

Nature Reviews Immunology

Abstract:Fundamental discoveries in many aspects of mammalian physiology have been made using laboratory mice as research models. These studies have been facilitated by the genetic tractability and inbreeding of such mice, the large set of immunological reagents that are available, and the establishment of environmentally controlled, high-throughput facilities. Such facilities typically include barriers to keep the mouse colonies free of pathogens and the frequent re-derivation of the mice severely limits their commensal flora. Because humans have co-evolved with microorganisms and are exposed to a variety of pathogens, a growing community of researchers posits that preclinical disease research can be improved by studying mice in the context of the microbiota and pathogens that they would encounter in the natural world. Here, we provide a perspective of how these different approaches can be combined and integrated to improve existing mouse models to enhance our understanding of disease mechanisms and develop new therapies for humans. We also propose that the term 'mice with natural microbiota' is more appropriate for describing these models than existing terms such as 'dirty mice'.

immunology
Facility-dependent metabolic phenotype and gut bacterial composition in CD-1 mice from a single vendor: A brief report

Allison L. Unger,Korin Eckstrom,Thomas L. Jetton,Jana Kraft

DOI: https://doi.org/10.1371/journal.pone.0238893

IF: 3.7

2020-09-21

PLoS ONE

Abstract:Utilization of murine models remains a valuable tool in biomedical research, yet, disease phenotype of mice across studies can vary considerably. With advances in next generation sequencing, it is increasingly recognized that inconsistencies in host phenotype can be attributed, at least in part, to differences in gut bacterial composition. Research with inbred murine strains demonstrates that housing conditions play a significant role in variations of gut bacterial composition, however, few studies have assessed whether observed variation influences host phenotype in response to an intervention. Our study initially sought to examine the effects of a long-term (9-months) dietary intervention (i.e., diets with distinct fatty acid compositions) on the metabolic health, in particular glucose homeostasis, of genetically-outbred male and female CD-1 mice. Yet, mice were shipped from two different husbandry facilities of the same commercial vendor (Cohort A and B, respectively), and we observed throughout the study that diet, sex, and aging differentially influenced the metabolic phenotype of mice depending on their husbandry facility of origin. Examination of the colonic bacteria of mice revealed distinct bacterial compositions, including 23 differentially abundant genera and an enhanced alpha diversity in mice of Cohort B compared to Cohort A. We also observed that a distinct metabolic phenotype was linked with these differentially abundant bacteria and indices of alpha diversity. Our findings support that metabolic phenotypic variation of mice of the same strain but shipped from different husbandry facilities may be influenced by their colonic bacterial community structure. Our work is an important precautionary note for future research of metabolic diseases via mouse models, particularly those that seek to examine factors such diet, sex, and aging.

multidisciplinary sciences
Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice

Aaron C. Ericsson,J. Wade Davis,William Spollen,Nathan Bivens,Scott Givan,Catherine E. Hagan,Mark McIntosh,Craig L. Franklin

DOI: https://doi.org/10.1371/journal.pone.0116704

IF: 3.7

2015-02-12

PLoS ONE

Abstract:The commensal gut microbiota has been implicated as a determinant in several human diseases and conditions. There is mounting evidence that the gut microbiota of laboratory mice (Mus musculus) similarly modulates the phenotype of mouse models used to study human disease and development. While differing model phenotypes have been reported using mice purchased from different vendors, the composition and uniformity of the fecal microbiota in mice of various genetic backgrounds from different vendors is unclear. Using culture-independent methods and robust statistical analysis, we demonstrate significant differences in the richness and diversity of fecal microbial populations in mice purchased from two large commercial vendors. Moreover, the abundance of many operational taxonomic units, often identified to the species level, as well as several higher taxa, differed in vendor- and strain-dependent manners. Such differences were evident in the fecal microbiota of weanling mice and persisted throughout the study, to twenty-four weeks of age. These data provide the first in-depth analysis of the developmental trajectory of the fecal microbiota in mice from different vendors, and a starting point from which researchers may be able to refine animal models affected by differences in the gut microbiota and thus possibly reduce the number of animals required to perform studies with sufficient statistical power.

multidisciplinary sciences
Failure of colonization following gut microbiota transfer exacerbates DSS-induced colitis

Kevin L Gustafson,Trevor R Rodriguez,Zachary L McAdams,Lyndon M Coghill,Aaron C Ericsson,Craig L Franklin

DOI: https://doi.org/10.1101/2024.09.25.614792

2024-09-25

Abstract:To study the impact of differing specific pathogen-free gut microbiomes (GMs) on a murine model of inflammatory bowel disease, selected GMs were transferred using embryo transfer (ET), cross-fostering (CF), and co-housing (CH). Prior work showed that the GM transfer method and the microbial composition of donor and recipient GMs can influence microbial colonization and disease phenotypes in dextran sodium sulfate-induced colitis. When a low richness GM was transferred to a recipient with a high richness GM via CH, the donor GM failed to successfully colonize, and a more severe disease phenotype resulted when compared to ET or CF, where colonization was successful. By comparing CH and gastric gavage for fecal material transfer, we isolated the microbial component of this effect and determined that differences in disease severity and survival were associated with microbial factors rather than the transfer method itself. Mice receiving a low richness GM via CH and gastric gavage exhibited greater disease severity and higher expression of pro-inflammatory immune mediators compared to those receiving a high richness GM. This study provides valuable insights into the role of GM composition and colonization in disease modulation.

Microbiology
The influence of caging, bedding, and diet on the composition of the microbiota in different regions of the mouse gut

Aaron C. Ericsson,Jonalyn Gagliardi,Delia Bouhan,William G. Spollen,Scott A. Givan,Craig L. Franklin

DOI: https://doi.org/10.1038/s41598-018-21986-7

IF: 4.6

2018-03-06

Scientific Reports

Abstract:Countless studies have identified differences between the gut microbiota of humans affected with myriad conditions and healthy individuals, and animal models are commonly used to determine whether those differences are causative or correlative. Recently, concerns have arisen regarding the reproducibility of animal models between institutions and across time. To determine the influence of three common husbandry-associated factors that vary between institutions, groups of weanling mice were placed in either static or ventilated microisolator caging, with either aspen or paperchip bedding, and with one of three commonly used rodent chows, in a fully crossed study design. After thirteen weeks, samples were collected from multiple regions of the gastrointestinal tract and characterized using culture-independent sequencing methods. Results demonstrated that seemingly benign husbandry factors can interact to induce profound changes in the composition of the microbiota present in certain regions of the gut, most notably the cecum, and that those changes are muted during colonic transit. These findings indicate that differences in factors such as caging and bedding can interact to modulate the gut microbiota that in turn may affect reproducibility of some animal models, and that cecal samples might be optimal when screening environmental effects on the gut microbiota.

multidisciplinary sciences
A guide to germ‐free and gnotobiotic mouse technology to study health and disease

Maude Jans,Lars Vereecke

DOI: https://doi.org/10.1111/febs.17124

2024-03-25

FEBS Journal

Abstract:Germ‐free and gnotobiotic mouse technology allows the unraveling of complex host–microbiota interactions within a reductionist framework. The implementation of these methodologies poses significant technical and experimental challenges. This review explores practical insights aimed at enhancing the precision and success of germ‐free and gnotobiotic experiments. The intestinal microbiota has major influence on human physiology and modulates health and disease. Complex host–microbe interactions regulate various homeostatic processes, including metabolism and immune function, while disturbances in microbiota composition (dysbiosis) are associated with a plethora of human diseases and are believed to modulate disease initiation, progression and therapy response. The vast complexity of the human microbiota and its metabolic output represents a great challenge in unraveling the molecular basis of host–microbe interactions in specific physiological contexts. To increase our understanding of these interactions, functional microbiota research using animal models in a reductionistic setting are essential. In the dynamic landscape of gut microbiota research, the use of germ‐free and gnotobiotic mouse technology, in which causal disease‐driving mechanisms can be dissected, represents a pivotal investigative tool for functional microbiota research in health and disease, in which causal disease‐driving mechanisms can be dissected. A better understanding of the health‐modulating functions of the microbiota opens perspectives for improved therapies in many diseases. In this review, we discuss practical considerations for the design and execution of germ‐free and gnotobiotic experiments, including considerations around germ‐free rederivation and housing conditions, route and timing of microbial administration, and dosing protocols. This comprehensive overview aims to provide researchers with valuable insights for improved experimental design in the field of functional microbiota research.

biochemistry & molecular biology
Rodent models for oral microbiome research: considerations and challenges- a mini review

Divya Gopinath,Deepak Pandiar,Zhengrui Li,Swagatika Panda

DOI: https://doi.org/10.3389/froh.2024.1439091

2024-10-01

Abstract:Rodent models have been commonly employed in oral microbiota research to investigate the relationship between bacteria and oral disease. Nevertheless, to apply the knowledge acquired from studies conducted on rodents to a human context, it is crucial to consider the significant spatial and temporal parallels and differences between the oral microbiota of mice and humans. Initially, we outline the comparative physiology and microbiology of the oral cavity of rodents and humans. Additionally, we highlight the strong correlation between the oral microbiome of rodents and genetic makeup, which is influenced by factors including vendor, husbandry practices, and environmental conditions. All of these factors potentially impact the replicability of studies on rodent microbiota and the resulting conclusions. Next, we direct our attention toward the diversity in the microbiome within mice models of disease and highlight the diversity that may potentially affect the characteristics of diseases and, in turn, alter the ability to replicate research findings and apply them to real-world situations. Furthermore, we explore the practicality of oral microbial models for complex oral microbial diseases in future investigations by examining the concept of gnotobiotic and germ-free mouse models. Finally, we stress the importance of investigating suitable techniques for characterizing and managing genetically modified organisms. Future research should consider these aspects to improve oral microbiome research's translational potential.
Decoding the microbiome: advances in genetic manipulation for gut bacteria

Ziying Chen,Wenbing Jin,Alex Hoover,Yanjie Chao,Yanlei Ma

DOI: https://doi.org/10.1016/j.tim.2023.05.007

IF: 15.9

2023-01-01

Trends in Microbiology

Abstract:Studies of the gut microbiota have revealed associations between specific bac-terial species or community compositions with health and disease, yet the causal mechanisms underlying microbiota gene-host interactions remain poorly under-stood. This is partly due to limited genetic manipulation (GM) tools for gut bacte-ria. Here, we review current advances and challenges in the development of GM approaches, including clustered regularly interspaced short palindromic repeats (CRISPR)-Cas and transposase-based systems in either model or non-model gut bacteria. By overcoming barriers to 'taming' the gut microbiome, GM tools allow molecular understanding of host-microbiome associations and accelerate microbiome engineering for clinical treatment of cancer and metabolic disorders. Finally, we provide perspectives on the future development of GM for gut microbiome species, where more effort should be placed on assembling a generalized GM pipeline to accelerate the application of groundbreaking GM tools in non-model gut bacteria towards both basic understanding and clinical translation.
Mouse Vendor Influence on the Bacterial and Viral Gut Composition Exceeds the Effect of Diet

Torben Sølbeck Rasmussen,Liv de Vries,Witold Kot,Lars Hestbjerg Hansen,Josué L. Castro-Mejía,Finn Kvist Vogensen,Axel Kornerup Hansen,Dennis Sandris Nielsen

DOI: https://doi.org/10.3390/v11050435

2019-05-13

Viruses

Abstract:Often physiological studies using mice from one vendor show different outcome when being reproduced using mice from another vendor. These divergent phenotypes between similar mouse strains from different vendors have been assigned to differences in the gut microbiome. During recent years, evidence has mounted that the gut viral community plays a key role in shaping the gut microbiome and may thus also influence mouse phenotype. However, to date inter-vendor variation in the murine gut virome has not been studied. Using a metavirome approach, combined with 16S rRNA gene sequencing, we here compare the composition of the viral and bacterial gut community of C57BL/6N mice from three different vendors exposed to either a chow-based low-fat diet or high-fat diet. Interestingly, both the bacterial and the viral component of the gut community differed significantly between vendors. The different diets also strongly influenced both the viral and bacterial gut community, but surprisingly the effect of vendor exceeded the effect of diet. In conclusion, the vendor effect is substantial not only on the gut bacterial community but also strongly influences viral community composition. Given the effect of GM on mice phenotype, this is essential to consider for increasing reproducibility of mouse studies.
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance

Stephan P. Rosshart,Brian G. Vassallo,Davide Angeletti,Diane S. Hutchinson,Andrew P. Morgan,Kazuyo Takeda,Heather D. Hickman,John A. McCulloch,Jonathan H. Badger,Nadim J. Ajami,Giorgio Trinchieri,Fernando Pardo-Manuel de Villena,Jonathan W. Yewdell,Barbara Rehermann

DOI: https://doi.org/10.1016/j.cell.2017.09.016

IF: 64.5

2017-11-01

Cell

Abstract:Laboratory mice, while paramount for understanding basic biological phenomena, are limited in modeling complex diseases of humans and other free-living mammals. Because the microbiome is a major factor in mammalian physiology, we aimed to identify a naturally evolved reference microbiome to better recapitulate physiological phenomena relevant in the natural world outside the laboratory. Among 21 distinct mouse populations worldwide, we identified a closely related wild relative to standard laboratory mouse strains. Its bacterial gut microbiome differed significantly from its laboratory mouse counterpart and was transferred to and maintained in laboratory mice over several generations. Laboratory mice reconstituted with natural microbiota exhibited reduced inflammation and increased survival following influenza virus infection and improved resistance against mutagen/inflammation-induced colorectal tumorigenesis. By demonstrating the host fitness-promoting traits of natural microbiota, our findings should enable the discovery of protective mechanisms relevant in the natural world and improve the modeling of complex diseases of free-living mammals. VIDEO ABSTRACT.

cell biology,biochemistry & molecular biology

How to decide who to treat.

Intra-aortic balloon pumping in cardiogenic shock.

The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host.

The role of the gut microbiota on animal model reproducibility

Controlled Complexity: Optimized Systems to Study the Role of the Gut Microbiome in Host Physiology

Identification of gut microbial species linked with disease variability in a widely used mouse model of colitis

Microbiome Composition in Both Wild-Type and Disease Model Mice Is Heavily Influenced by Mouse Facility

Temporospatial shifts within commercial laboratory mouse gut microbiota impact experimental reproducibility

[Subacute toxic hepatitis and perhexiline maleates].

How informative is the mouse for human gut microbiota research?

Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design

Integrating natural commensals and pathogens into preclinical mouse models

Facility-dependent metabolic phenotype and gut bacterial composition in CD-1 mice from a single vendor: A brief report

Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice

Failure of colonization following gut microbiota transfer exacerbates DSS-induced colitis

The influence of caging, bedding, and diet on the composition of the microbiota in different regions of the mouse gut

A guide to germ‐free and gnotobiotic mouse technology to study health and disease

Rodent models for oral microbiome research: considerations and challenges- a mini review

Decoding the microbiome: advances in genetic manipulation for gut bacteria

Mouse Vendor Influence on the Bacterial and Viral Gut Composition Exceeds the Effect of Diet

Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance